Search Results 381-390 of 17425 for Oncogene

  1. Publications - Krishnan Ramanujan, M.D. - Mayo Clinic

    Oncogenic NRAS, Required for Pathogenesis of Embryonic Rhabdomyosarcoma, Relies upon the HMGA2–IGF2BP2 Pathway Cancer Research. 2013; 73(10):3041-3050. View ...

  2. Skin Cancer Clinical Trials - Mayo Clinic Research

    ... oncogene homolog B1 (BRAF) inhibitor or mitogen-activated protein kinase (MEK) enzyme inhibitor when indicated. Participants cannot be eligible for or have ...

  3. Publications - Ray Guo, M.D., Ph.D. - Mayo Clinic

    Oncogene. 2018 Jan 22 [Epub ahead of print] View PubMed; Ramos Rodriguez AJ ... PPP6R3-USP6 amplification: Novel oncogenic mechanism in malignant nodular ...

  4. A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer (MOUNTAINEER-03) - Mayo Clinic

    Participant has rat sarcoma viral oncogene homolog wild-type (RAS WT) disease as determined by local or central testing. For central RAS analysis, tissue ...

  5. Overview - Stem Cell and Cancer Biology Laboratory - Mayo Clinic Research

    ... oncogenic states in conditions such as aging and cancer. A clear understanding of stem cell differentiation processes and the biology of cancer risk ...

  6. A Study to Test How Well Different Doses of BI 3706674 Are Tolerated by People With Advanced Cancer in the Stomach and Oesophagus - Mayo Clinic

    ... oncogene homolog (KRAS) wild type (wt) amplification and documented disease progression despite at least 1 line of prior therapy. KRAS status will be ...

  7. Overview - Stem Cell and Cancer Biology Laboratory - Mayo Clinic Research

    ... oncogenic states in conditions such as aging and cancer. A clear understanding of stem cell differentiation processes and the biology of cancer risk ...

  8. Cancer News - Medical Professionals - Mayo Clinic

    Medical Professionals news and the latest information about Cancer.

  9. B-Cell Lymphoma Clinical Trials - Mayo Clinic Research

    Recent reports have identified a specific oncogenic mutation L265P of the MYD88 gene in approximately 30% of the patients with the activated B-cell (ABC) type ...

  10. Hodgkin Clinical Trials - Mayo Clinic Research

    This phase I trial studies the side effects and the best dose of everolimus when given together with brentuximab vedotin in treating patients with Hodgkin ...